← All indications
Uveal Neoplasms
Tumors or cancer of the UVEA.
Subtype terms (3)
More specific conditions that are subtypes of Uveal Neoplasms in the MeSH hierarchy.
- Choroid Neoplasms
1 drug experimental
- Iris Neoplasms
- Uveal Melanoma
Drugs by status
Approved for this indication (1)
Phase 2 trials (1)
Organizations
Organization Involved with Phase 3 Indications (14)
Organization Involved with Phase 2 Indications (53)
- Incyte
- Spectrum Pharmaceuticals
- Bristol-Myers Squibb
- Merck
- Exelixis
- Genentech
- Pfizer
- Novartis
- Allergan
- Array BioPharma
- BioMed Valley Discoveries, Inc
- GlaxoSmithKline
- Immunocore Ltd
- Syndax Pharmaceuticals
- Vanquish Oncology, Inc.
- Vastra Gotaland Region
- University Hospital, Essen
- University of Pittsburgh
- Cancer Research UK
- Cornell University
- Harvard University
- Duke University
- University of Washington
- Grupo Español Multidisciplinar de Melanoma
- HealthPartners Institute
- Hoosier Cancer Research Network
- Institut Català d'Oncologia
- Radboud University
- Southwest Oncology Group
- Thomas Jefferson University
- +23 more
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (2)